Stevanato Group (NYSE:STVN) Shares Gap Up – Here’s Why

Shares of Stevanato Group S.p.A. (NYSE:STVN) gapped up before the market opened on Wednesday . The stock had previously closed at €14.73, but opened at €16.13. Stevanato Group shares last traded at €16.79, with a volume of 237,943 shares traded.

Trending Headlines about Stevanato Group

Here are the key news stories impacting Stevanato Group this week:

• Positive Sentiment: Reported FY‑2025 revenue up 7% (9% at constant currency) with record revenue from high‑value solutions and expanded margins — supports longer‑term growth narrative for pharma packaging/delivery exposure. Business Wire
• Positive Sentiment: Market reaction: multiple outlets say the stock surged after quarter — investors appear encouraged by the beat/metrics and growth mix. Investing.com: Surge on Q4 beat
• Neutral Sentiment: Earnings detail is mixed across reports: some outlets (Zacks) cite a modest EPS beat (reported $0.21 vs $0.20 est.), while other sources show different euro‑based EPS figures — check the company materials for GAAP vs FX/cc differences and one‑offs. Zacks
• Neutral Sentiment: Revenue growth in Q4 was modestly positive (reported up ~5% year‑over‑year, ~7% CC), showing steady demand but not accelerating materially — supports the recovery story but limits upside surprise potential. Business Wire
• Negative Sentiment: Company‑reported EPS in euro terms missed one consensus read (€0.17 vs €0.20), which could signal currency/translation effects or different accounting views and adds short‑term uncertainty. MarketBeat
• Negative Sentiment: FY‑2026 EPS guidance was set at €0.690–0.730, with the top end roughly in line with consensus but not above it — modestly constraining upside if investors were looking for a more bullish outlook. MarketBeat: Guidance Summary
• Negative Sentiment: Analyst coverage notes a strategic shift toward high‑value products that should lift margins long term, but warns the near‑term results represent an “earnings test” — raises caution on execution and timing. Investing.com: Analyst Note

Analyst Upgrades and Downgrades

A number of brokerages recently issued reports on STVN. Weiss Ratings reissued a “hold (c)” rating on shares of Stevanato Group in a research report on Monday, December 29th. Jefferies Financial Group set a $17.50 price target on shares of Stevanato Group in a research note on Tuesday, February 10th. Morgan Stanley initiated coverage on shares of Stevanato Group in a report on Monday, December 1st. They issued an “equal weight” rating and a $24.00 target price for the company. Finally, Wall Street Zen cut Stevanato Group from a “buy” rating to a “hold” rating in a research note on Saturday, February 14th. One equities research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy”.

Stevanato Group Trading Up 8.8%

The firm has a market capitalization of $4.85 billion, a price-to-earnings ratio of 28.16, a PEG ratio of 1.21 and a beta of 0.57. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.30 and a current ratio of 1.89. The company has a 50-day moving average price of €17.86 and a 200-day moving average price of €21.78.

Stevanato Group (NYSE:STVN) last posted its earnings results on Wednesday, March 4th. The company reported €0.17 earnings per share for the quarter, missing the consensus estimate of €0.20 by (€0.03). Stevanato Group had a return on equity of 10.52% and a net margin of 11.99%.Stevanato Group’s revenue was up 4.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.18 EPS. Stevanato Group has set its FY 2026 guidance at 0.690-0.730 EPS. As a group, research analysts forecast that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.

Hedge Funds Weigh In On Stevanato Group

Large investors have recently bought and sold shares of the stock. First Horizon Advisors Inc. raised its position in Stevanato Group by 14.9% during the 2nd quarter. First Horizon Advisors Inc. now owns 3,833 shares of the company’s stock worth $94,000 after buying an additional 497 shares during the last quarter. PNC Financial Services Group Inc. raised its holdings in Stevanato Group by 7.7% during the second quarter. PNC Financial Services Group Inc. now owns 9,893 shares of the company’s stock worth $242,000 after purchasing an additional 711 shares in the last quarter. First Bank & Trust lifted its position in Stevanato Group by 5.6% in the fourth quarter. First Bank & Trust now owns 17,109 shares of the company’s stock valued at $344,000 after purchasing an additional 904 shares during the period. GW&K Investment Management LLC boosted its holdings in Stevanato Group by 76.2% in the 4th quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock valued at $49,000 after purchasing an additional 1,055 shares in the last quarter. Finally, Pathstone Holdings LLC increased its position in Stevanato Group by 1.5% during the 3rd quarter. Pathstone Holdings LLC now owns 71,178 shares of the company’s stock worth $1,833,000 after purchasing an additional 1,067 shares during the period.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.